OSE Immunotherapeutics

ISIN: FR0012127173 | Ticker: OSE

Health Care > Pharmaceuticals, Biotechnology & Life Sciences > Biotechnology > Biotechnology

About OSE Immunotherapeutics

Company Description

OSE Immunotherapeutics is an integrated biotechnology company focused on developing and partnering therapies to control the immune system for immuno-oncology and autoimmune diseases.

Based in Nantes (Head Office) and Paris, OSE Immunotherapeutics has 70 employees and is listed on Euronext Paris.

Year founded

2016

Served area

Worldwide

Headcount

Headquarters

22 Boulevard Benoni Goullin, 44200 Nantes – France

Shareholder information

Shares outstanding

18,527,401

IPO

March 30, 2015

Stock exchange(s)

Euronext Paris

Contact

Email address

First name

Last name

Phone number

Company

Your message

Yes, I have read, understand and agree to the Privacy Policy

Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.

OSE Immunotherapeutics

About OSE Immunotherapeutics

Shareholder information

Contact

Newsletter